- Home
- NWTG vs MYNZ Comparison
NWTG vs MYNZ Comparison
Compare NWTG & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTG
- MYNZ
- Stock Information
- Founded
- NWTG 2018
- MYNZ 2021
- Country
- NWTG United States
- MYNZ Germany
- Employees
- NWTG N/A
- MYNZ N/A
- Industry
- NWTG Recreational Games/Products/Toys
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- NWTG Consumer Discretionary
- MYNZ Health Care
- Exchange
- NWTG Nasdaq
- MYNZ Nasdaq
- Market Cap
- NWTG 8.3M
- MYNZ 8.0M
- IPO Year
- NWTG N/A
- MYNZ 2021
- Fundamental
- Price
- NWTG $1.65
- MYNZ $2.08
- Analyst Decision
- NWTG
- MYNZ Buy
- Analyst Count
- NWTG 0
- MYNZ 2
- Target Price
- NWTG N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- NWTG 246.6K
- MYNZ 93.5K
- Earning Date
- NWTG 08-04-2025
- MYNZ 06-17-2025
- Dividend Yield
- NWTG N/A
- MYNZ N/A
- EPS Growth
- NWTG N/A
- MYNZ N/A
- EPS
- NWTG N/A
- MYNZ N/A
- Revenue
- NWTG $4,305,000.00
- MYNZ $893,991.00
- Revenue This Year
- NWTG $98.37
- MYNZ $26.06
- Revenue Next Year
- NWTG $49.25
- MYNZ $4.97
- P/E Ratio
- NWTG N/A
- MYNZ N/A
- Revenue Growth
- NWTG 606.90
- MYNZ N/A
- 52 Week Low
- NWTG $1.35
- MYNZ $1.92
- 52 Week High
- NWTG $195.00
- MYNZ $34.00
- Technical
- Relative Strength Index (RSI)
- NWTG N/A
- MYNZ 38.07
- Support Level
- NWTG N/A
- MYNZ $1.93
- Resistance Level
- NWTG N/A
- MYNZ $2.10
- Average True Range (ATR)
- NWTG 0.00
- MYNZ 0.16
- MACD
- NWTG 0.00
- MYNZ 0.04
- Stochastic Oscillator
- NWTG 0.00
- MYNZ 30.39
About NWTG Newton Golf Company Inc. Common Stock
Newton Golf Co is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.